Trade

with

BioTime Inc
(Amex: BTX)
AdChoices
3.25
-0.11
-3.27%
After Hours :
3.25
0.00
0.00%

Open

3.39

Previous Close

3.36

Volume (Avg)

110.83k (244.19k)

Day's Range

3.25-3.40

52Wk Range

2.21-4.18

Market Cap.

239.49M

Dividend Rate ( Yield )

-

Beta

0.97

Shares Outstanding

68.29M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 4.43M

    • Net Income

    • -43.88M

    • Market Cap.

    • 239.49M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -966.76

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.97

    • Forward P/E

    • -

    • Price/Sales

    • 39.37

    • Price/Book Value

    • 16.61

    • Price/Cash flow

    • -5.27

      • EBITDA

      • -52.03M

      • Return on Capital %

      • -87.35

      • Return on Equity %

      • -261.79

      • Return on Assets %

      • -87.35

      • Book Value/Share

      • 0.20

      • Shares Outstanding

      • 68.29M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -9.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 24.14

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 83.02

            • 82.75

            • Pre-Tax Margin

            • -1,328.11

            • 39.38

            • Net Profit Margin

            • -966.76

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 94.20

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -497.40

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.76

              • Current Ratio

              • 3.68

              • 2.92

              • Quick Ratio

              • 3.34

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 4.58

              • 2.21

              • Book Value/Share

              • 0.20

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.12

                • 277.78

                • P/E Ratio 5-Year High

                • -12.45

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.77

                • 124.82

                • Price/Sales Ratio

                • 39.84

                • 9.35

                • Price/Book Value

                • 16.84

                • 8.50

                • Price/Cash Flow Ratio

                • -5.27

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -261.79

                    (-190.40)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -87.35

                    (-59.00)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -260.10

                    (-173.60)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • 5.03

                  • 1.48

                  • Asset Turnover

                  • 0.09

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -55.99M
                  Operating Margin
                  -1,262.54
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -5.27
                  Ownership

                  Institutional Ownership

                  39.76%

                  Top 10 Institutions

                  37.86%

                  Mutual Fund Ownership

                  6.05%

                  Float

                  58.93%

                  5% / Insider Ownership

                  19.39%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • iShares Russell 2000 (AU)

                  •  

                    794,120

                  • -0.90

                  • 1.15

                  • Vanguard Total Stock Mkt Idx

                  •  

                    564,987

                  • 13.16

                  • 0.77

                  • British & American Investment Trust PLC

                  •  

                    535,524

                  • 138.20

                  • 0.94

                  • Vanguard Extended Market Index Fund

                  •  

                    367,356

                  • 3.81

                  • 0.50

                  • iShares Russell 2000 Growth

                  •  

                    362,531

                  • -0.45

                  • 0.53

                  • Vanguard Instl Total Stock Market Index

                  •  

                    260,899

                  • 0.00

                  • 0.35

                  • CREF Stock

                  •  

                    162,588

                  • 6.82

                  • 0.22

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    128,062

                  • 0.00

                  • 0.17

                  • Bridgeway Ultra Small Company Market

                  •  

                    123,800

                  • 0.00

                  • 0.19

                  • iShares Micro-Cap

                  •  

                    110,355

                  • 0.84

                  • 0.16

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • BROADWOOD CAPITAL INC

                  •  

                    17,882,785

                  • +32.74%

                  • 24.27

                  • Asterias Biotherapeutics, Inc

                  •  

                    3,852,880

                  • -56.72%

                  • 5.34

                  • BlackRock Fund Advisors

                  •  

                    1,762,522

                  • +6.15%

                  • 2.64

                  • Vanguard Group, Inc.

                  •  

                    1,216,964

                  • +1.61%

                  • 1.82

                  • Ycmnet Advisors Inc

                  •  

                    594,645

                  • 0.00%

                  • 0.81

                  • British & American Investment Trust PLC

                  •  

                    535,524

                  • +138.20%

                  • 0.94

                  • State Street Corp

                  •  

                    508,189

                  • +0.30%

                  • 0.76

                  • Northern Trust Investments, N.A.

                  •  

                    440,867

                  • -4.22%

                  • 0.66

                  • Morgan Stanley Smith Barney LLC

                  •  

                    215,456

                  • +0.70%

                  • 0.32

                  • Geode Capital Management, LLC

                  •  

                    199,712

                  • +7.90%

                  • 0.30

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  Small Core

                  BioTime Inc was incorporated in 1990 in the state of California. It is a biotechnology company engaged in two areas of biomedical research and product development. Its main focus is in the field of regenerative medicine; specifically...more human embryonic stem (hES) cell and induced pluripotent stem (iPS) cell technology. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. hES and iPS cells provide a means of manufacturing every cell type in the human body and therefore show considerable promise for the development of a number of new therapeutic products. Its core technologies center on stem cells capable of becoming all of the cell types in the human body, a property called pluripotency. ...moreProducts made from these pluripotent stem cells are being developed by the Company and its subsidiaries, for use in various fields of medicine, including: neuroscience, oncology, orthopedics, and blood and vascular diseases. HyStem, Hextend, ESpy, PureStem, and PentaLyte are registered trademarks of the Company and Renevia, Premvia, ReGlyde, and ESpan are trademarks of the Company.lessless

                  Key People

                  Dr. Michael D. West,PhD

                  CEO/Director/Vice President, Subsidiary

                  Pedro Lichtinger

                  CEO, Subsidiary/Director/President, Subsidiary

                  Alfred D. Kingsley

                  Chairman of the Board/Director

                  Mr. Robert W. Peabody

                  CFO/Chief Accounting Officer/COO/Senior VP

                  Judith Segall

                  Director/Secretary/Vice President, Divisional

                  • BioTime Inc

                  • 1301 Harbor Bay Parkway

                  • Alameda, CA 94502

                  • USA.Map

                  • Phone: +1 510 521-3390

                  • Fax: +1 510 521-3389

                  • biotimeinc.com

                  Incorporated

                  1990

                  Employees

                  109

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: